Page 190 - CW E-Magazine (25-6-2024)

Special Report

1 Biosimilar opporutnity

+9%
26
25
22 15% 18%
+36%
13% 9% 9%
17 8%
11%
8% 35%
12 42% 39%
9%
-8% 42%
7
10% -8% 38%
35% 37% 36% 37%
45% 39%
46%
2018 2019 2020 2021 2022 2023

EU4 is france, Germany, Italy & Spain.
Row is rest of world.
* Not approved

Fig. 6: Global Biosimilars Market
Source: IQVIA Thought Leadership; IQVIA MIDAS Q42023, RX only

demic levels when excluding launches ues to grow with global sales reach- Biosimilars represent a much smaller Offi ce No. 123, 1st Floor, Ajay Industrial Estate,
in vaccines and GLP-1 drug launches ing $307-billion in 2023, growing market than small-molecule generic B. Anjirwadi, Mazgaon, Mumbai - 400 010.
in obesity (see Figure 4). at a compound annual growth rate drugs, with the global biosimilars mar- Mob.: +91-9870194496 / +91-9833118324
Tel.: 022-49724799
(CAGR) of 4% between 2021-2023 ket valued at $26-billion in 2023, but info@relicchemicals.com
Generics and biosimilars market (see Figure 5). growth has been higher, approximately www.relicchemicals.com
Turning to generics, always a very 9% between 2021-2023 (see Figure 6).
competitive market, there has been a On a regional basis, the US ac- The EU4 (France, Germany, Italy and PIONEERS IN GRIGNARD CHEMISTRY SINCE 1978 / 1200MT installed capacity MANUFACTURERS / SUPPLIERS OF
ALCOHOL DENATURANTS / BITTERANTS
shift in the competitive landscape. Al- counts for the largest market share with Spain) and the UK combined are the Acid Chlorides: Acid Anhydrides:  ACETALDEHYDE
ready a highly fragmented market, that 27% of the market, followed by Europe leading market for biosimilars with a  Decanoyl Chloride  Propionic Anhydride Grignard Reagents:  CROTONALDEHYDE
 Methyl Magnesium Chloride/Bromide
fragmentation has further increased. In at 22%, and China at 18%. Over the 37% market share, followed by the US  Undecanoyl Chloride  Hexanoic Anhydride  Phenyl Magnesium Chloride/Bromide  DENATONIUM BENZOATE
2023, the top 10 generics companies past fi ve years (2018-2023), Europe at 35%, the rest of Europe (9%), and the  Isovaleryl Chloride  Heptanoic Anhyride  Tert - Butyl Magnesium Chloride  DENATONIUM SACCHARIDE
 Ethyl Magnesium Bromide
 PYRIDINE BASE
accounted for 21% of the global mar- as a whole contributed almost 30% of rest of the world (18%).  2-Furoyl Chloride  Isobutyric Anhydride  Isopropyl Magnesium Chloride  CAOUTCHOUCINE
ket, down from 28% in 2016. Indian generics market growth, which includes  Pyrophosphoryl Chloride  N-Butyric Anhydride 2M in THF The Lakshmiji Organics Pvt. Ltd.
 Isopropyl Magnesium
companies have had a major impact, 18% combined growth in the EU4 Given the quality of biosimilars  Hexanoyl Chloride  Valeric Anhydride Chloride 1.3 M in THF (LiCL complex) Sitapur, UP. Mob.: 09322661064
especially in the US. Illustrative of that (France, Germany, Italy, and Spain) and which are now recognized globally, and  N-Butyryl Chloride Intermediates Personal care: Email: organics@lakshmiji.com / loplstp@gmail.com
 Novaguard EHG (Ethylhexyl Glycerine)
trend is that in 2023, 50% of the abbre- the UK, while the US has contributed although the US has been much slower  Isobutyryl Chloride  5-Ethylpyridine-2-Ethanol  Novaguard PE (Phenoxy ethanol)
viated new drug applications (ANDAs) less than 5% to global growth. Non- to acknowledge this, biosimilar sales  Lauroyl Chloride  2,4-Thiazolidine Dione  Novaguard CG (Caprylyl Glycol) IMPORT \ EXPORT DATA
 Novaguard HG (1,2-Hexanediol)
in the US were from Indian manufac- core markets have experienced stron- are likely to grow much faster than  Octanoyl Chloride  Isosorbide  Novaguard DMI (Dimethyl Isosorbide) Any Chapter Rs.500 per month
turers. In 1990, only 15% were from ger growth than the US, including the the market as a whole over the next 10  Heptanoyl Chloride  1-Piperidine-1-Cyclohexene  Novaguard PG (1,2-Petanediol) CHEMLINK SOFTWARE
Indian companies. Commonwealth of Independent States years, although current technologies in ANY SPECIALITY ACID CHLORIDES, GRIGNARD AND PERSONAL CARE INGREDIENTS PER REQUEST MUMBAI
(CIS) with a CAGR of 11%, India with manufacturing make it clear that many novaphene specialities pvt ltd
On a product basis, the market for a CAGR of 10%, and Latin America biologics are not fi nancially viable as HO: 810, Techno IT Park, Link Road, Eksar, Borivali (W), Mumbai - 400 092. Maharashtra. INDIA Mr. Bhavin Patel
8469140555
small-molecule generic drugs contin- with a CAGR of 9% (see Figure 5). biosimilars. Factory: Unit 1: E-107 MIDC Tarapur, Boisar, District Palghar, Maharashtra - 401 506. INDIA chemlinksoft@gmail.com
Unit 2: N-27 MIDC Tarapur, Boisar, District Palghar, Maharashtra - 401 506. INDIA
Tel: +91-7410092952 / 7249317534  Email: sales@novaphene.com  Web: www.novaphene.com
19/48
190 Chemical Weekly June 25, 2024

Contents Index to Advertisers Index to Products Advertised